Why Oasis Clinical Research Stands Out in Pharma Trials
Oasis Clinical Research tackles patient recruitment with a data‑driven approach that slashes enrollment times by 30%. Their proprietary matching algorithm leverages real‑world evidence to identify eligible participants faster than traditional methods, giving sponsors a clear edge. This focus on speed and precision reshapes how trials reach critical milestones.
What Makes Their Patient Recruitment Unique
Recruitment at Oasis hinges on a dynamic database that merges electronic health records, insurance claims, and patient registries. By cross‑referencing diagnostic codes, medication histories, and demographic variables, they pinpoint candidates who meet complex eligibility criteria in minutes. The system flags potential matches before the sponsor even drafts the screening protocol, eliminating redundant queries and shortening the funnel from inquiry to enrollment.
How Data Integrity Is Ensured at Oasis
Data integrity is maintained through a multi‑layered verification framework. Every entry undergoes automated consistency checks, followed by manual audit trails that log every edit with time stamps and user IDs. Encryption at rest and in transit protects against tampering, while periodic external audits validate that the system complies with GCP, 21 CFR Part 11, and ISO 27001 standards.
Where Does Oasis Operate Globally?
Oasis operates across North America, Europe, and Asia, with regional hubs in Boston, London, and Singapore. Each hub tailors recruitment strategies to local regulatory landscapes and cultural nuances, ensuring seamless integration of site‑specific data. The global footprint also allows sponsors to launch multinational studies with a single, unified data management platform.
When Do Sponsors See Faster Results
Sponsors observe accelerated timelines when Oasis partners early in protocol design. By incorporating patient‑centric endpoints and adaptive randomization from the outset, the company reduces Phase II enrollment from 12 to 8 months on average. Early data reviews and interim analyses, powered by their real‑time dashboards, provide actionable insights that keep studies on schedule.
Why Do Regulators Trust Oasis Findings
Regulators trust Oasis findings because the firm adheres to a rigorous validation cycle. Before data release, every dataset undergoes a double‑blind reconciliation against source documents. The audit trail and version control satisfy FDA and EMA audit requirements, and the company routinely participates in external proficiency testing to benchmark against industry peers.
Frequently Asked Questions
how long does it take for a clinical trial to enroll patients with oasis clinical research?
Typically, enrollment times drop by about 30% compared to industry averages. This reduction stems from their advanced matching algorithms and real‑world data integration, which accelerate patient identification and screening.
is oasis clinical research certified by the fda for data handling?
Yes, Oasis holds FDA 21 CFR Part 11 certification for electronic records and signatures, ensuring that all clinical data meet regulatory compliance standards for integrity and security.
can sponsors use oasis clinical research for phase i trials?
Absolutely. Oasis supports trials from Phase I onward, offering tailored recruitment strategies and data management services that align with the specific safety and pharmacokinetic focus of early‑phase studies.